MedTrace Logo

Fish Oil and Aspirin With Type 2 Diabetes

NCT01181882 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-10-08

No results posted yet for this study

Summary

The purpose of this study is to understand if omega-3 fatty acids in fish oil enhance the ability of aspirin to reduce the risk of cardiovascular diseases such as heart attack and stroke in those who have diabetes mellitus.

Conditions

Interventions

DIETARY_SUPPLEMENT

Fish Oil and Aspirin

4 grams of fish oil each day for 28 days and 81 mg aspirin

Sponsors & Collaborators

  • Cornell University

    collaborator OTHER

  • Albany College of Pharmacy and Health Sciences

    collaborator OTHER

  • University of Rochester

    lead OTHER

Principal Investigators

  • Robert C Block, MD, MPH · University of Rochester

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-03-31
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01181882 on ClinicalTrials.gov